本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BriaCell Therapeutics Corp.

4.00
-0.1000-2.44%
盤後3.99-0.0103-0.26%19:57 EDT
成交量:41.93萬
成交額:168.73萬
市值:2,710.44萬
市盈率:-0.58
高:4.13
開:4.05
低:3.92
收:4.10
資料載入中...
2021/03/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/18

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/18

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/03

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/15

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/14

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/23

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/12/22

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/10

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/12/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/20

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/10/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/18

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/27

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/27

SEC問詢函

CORRESP [Cover] - Correspondence